title: Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma.
authors.affiliation: Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, 55 Fruit Street, Yawkey 9E, Boston, MA 02114, USA. egerstner@partners.org
authors.forename: E R
authors.initials: ER
authors.lastname: Gerstner
authors.forename: S
authors.initials: S
authors.lastname: Yip
authors.forename: D L
authors.initials: DL
authors.lastname: Wang
authors.forename: D N
authors.initials: DN
authors.lastname: Louis
authors.forename: A J
authors.initials: AJ
authors.lastname: Iafrate
authors.forename: T T
authors.initials: TT
authors.lastname: Batchelor
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D016543:Central Nervous System Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism; D019175:DNA Methylation; D005260:Female; D005909:Glioblastoma / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008297:Male; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000235:genetics* / Q000378:metabolism; D011237:Predictive Value of Tests; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; D019853:O(6)-Methylguanine-DNA Methyltransferase